Moolec Science SA Files Interim Financial Report
Ticker: MLECW · Form: 6-K · Filed: Apr 18, 2024 · CIK: 1937737
Sentiment: neutral
Topics: financial-reporting, interim-results
TL;DR
Moolec Science SA dropped its latest financials, check 'em out.
AI Summary
Moolec Science SA filed a Form 6-K on April 18, 2024, to report its unaudited interim condensed consolidated financial statements as of December 31, 2023, and June 30, 2023, and for the periods ended December 31, 2023, and 2022. The company is incorporated in Luxembourg and its fiscal year ends on June 30.
Why It Matters
This filing provides investors with an update on Moolec Science SA's financial performance and position for the interim periods, allowing for assessment of the company's health and progress.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Moolec Science SA (company) — Registrant
- December 31, 2023 (date) — Financial reporting period end
- June 30, 2023 (date) — Financial reporting period end
- December 31, 2022 (date) — Financial reporting period
FAQ
What type of financial statements are included in this 6-K filing?
The filing includes unaudited interim condensed consolidated financial statements.
What are the specific dates for which financial data is provided?
The financial statements are as of December 31, 2023, and June 30, 2023, and for the three-month and six-month periods ended December 31, 2023, and 2022.
What is the filing date of this Form 6-K?
The filing date is April 18, 2024.
Where is Moolec Science SA incorporated?
Moolec Science SA is incorporated in Luxembourg.
What is Moolec Science SA's fiscal year end?
Moolec Science SA's fiscal year ends on June 30.
Filing Stats: 184 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-04-18 16:32:32
Filing Documents
- ea0204137-6k_moolec.htm (6-K) — 9KB
- ea020413701ex99-1_moolec.htm (EX-99.1) — 343KB
- 0001213900-24-034133.txt ( ) — 354KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2024 Commission File Number: 001-41586 MOOLEC SCIENCE SA (Exact name of Registrant as Specified in Its Charter) 17, Boulevard F. W. Raiffeisen L-2411 Luxembourg, Grand Duchy of Luxembourg (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT LIST Exhibit No. Description 99.1 Moolec Science SA unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023 and for the three-month and six-month periods ended December 31, 2023 and 2022. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: April 18, 2024 By: /s/ Gastón Paladini Name: Gastón Paladini Title: Chief Executive Officer 2